QMR Technology Tackles The Most Pervasive and Complex Forms of Dry Eye
0%
4,3 % of current treatments for Dry Eye Disease
are provided with medical devices. The current therapeutic options available are based on light, heat or mechanical expression, but mainly only to alleviate symptoms at short or mid term and only for one type of DED, the Evaporative Dry Eye Disease (EDED).
0%
80% of cases are the patients who are suffering from the mixed ADDE (Aqueous Deficient Dry Eye) / EDE (Evaporative Dry Eye) forms of dry eye.
QMR® Technology is proven to be biologically safe.
0
genes
More than 300 Patients have Partecipated in Clinical Studies with the Rexon-Eye Device.
0
PATIENTS
Regenerative Process of QMR in Ophthalmology
What makes QMR® technology unique and innovative is its capacity to stimulate biological tissue, promoting the anti- inflammatory effect and stimulating the natural regeneration of cells and tissues.